Cytokeratin 18 and soluble cluster of differentiation-36: markers for nephropathy in patients with metabolic dysfunction-associated fatty liver disease
Hassan Shora, Ibrahim M. El‐Deen, Naglaa M. El-Lithy, Dina Mohamed Abo–Elmatty et autres
Abstract Background Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) is considered the hepatic aspect of metabolic disorders and is associated with an increased risk of chronic kidney disease (CKD). Aim This study aimed to assess the potential association of Cytokeratin-18 (CK-18) and soluble …
au, Égypte (code pays fourni par la source)
0 citations
The Egyptian Journal of Internal Medicine